Sponsor Scientific Institute San RaffaeleWhere Italy (1 site)Studying Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation, Support treatment, cardiac medical treatment, aetiology-specific treatmentUpdated 23 Sept 2024

See details

Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Peripartum cardiomyopathy studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Italy United States

Keep watching

Get an email when a new Peripartum cardiomyopathy study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:563 ↗

About Peripartum cardiomyopathy

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Bromocriptine (Parlodel)

Phase 2/3Taurine (O-due)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).